For more information:
AAPS Communications Manager
AAPS Recognizes Importance of Quality Throughout Pharmaceutical Continuum
New Resources Available in Support of Quality Month
Arlington, VA—New AAPS resources addressing pharmaceutical quality will be available throughout the month of November as AAPS participates in World Quality Month, an annual celebration led by the American Society for Quality (ASQ) and ASQExcellence (ASQE). The event recognizes the “vital role of quality professionals in achieving excellence through quality and the positive impact that quality makes in our organizations and communities around the world.”
The new resources include articles in the AAPS Newsmagazine. The cover story, “Quality-by-Design for Next-Generation Process Control,” examines quality approaches within manufacturing and across the pharmaceutical supply chain. A feature from Redica Systems Senior GMP Quality Expert Jerry Chapman analyzes the first FDA Warning Letter issued to an excipient-only manufacturer. Later in the month, a Q&A interview with Pharmatech Associates Managing Director Stephanie Gaulding will be published that examines available quality approaches in drug development and manufacturing.
“Quality is so important to every aspect of the pharmaceutical sciences,” AAPS Executive Director Tina Morris, Ph.D., said. “From discovery to R&D to commercialization to manufacturing and delivery, quality must be embedded at every stage of the pharmaceutical continuum to ensure patients receive safe and effective treatments.”
“AAPS members recognize the critical nature of quality in every part of the pharmaceutical discovery and delivery pipeline,” 2024 AAPS President Gopi Shankar, Ph.D., M.B.A., FAAPS, said. “Throughout my career, I’ve seen how important it is to vigorously support approaches to ensuring quality. AAPS’ profile as a leader in credible science shows our dedication to practices that result in high-quality drugs, beginning with strong peer-reviewed research on the applications of that research within pharma and biotech.”
In December, AAPS recognition of quality continues with a webinar produced in collaboration with the U.S. Pharmacopeia (USP) to discuss updates to a bacterial endotoxins chapter that includes standards for additional reagents.
The articles can be accessed on the AAPS Newsmagazine site. AAPS social media content can be followed using the #QualityMonth and #WorldQualityMonth hashtags.
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org